Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single Blind, Multicenter, Therapeutic Confirmatory Study to Assess the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children

NCT02164110 is registered in ClinicalTrials.gov with EuBiologics Co.,Ltd as lead sponsor.

NCT NCT02164110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02164110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single Blind, Multicenter, Therapeutic Confirmatory Study to Assess the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children
Lead sponsor
EuBiologics Co.,Ltd
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2014
Completion date
October 31, 2014
Enrollment
3,632 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention harmful effects